This study demonstrated a favorable short-term safety profile after a third dose of the BNT162b2 vaccine among healthcare workers (HCWs). There were more frequent local reactions and less systemic reactions compared to the second dose. The HCWs who reported reactions had higher prebooster titer of anti-S1 antibodies compared to those who reported no reactions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755369 | PMC |
http://dx.doi.org/10.1093/ofid/ofab656 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!